|
|
Advisory Board
The program and speaker panel for the Cell & Gene Therapy Forum 2011 is being directed by our Advisory Board, with whom we are working closely to ensure that all the most important topics are being covered.
The Advisory Board for the 2011 forum is:
- Alan E. Smith, PhD, Senior Vice President, Research; Chief Scientific Officer, Genzyme
- Dr Mitchell H. Gold, President & CEO, Dendreon Corporation
- Dr John McNeish, Executive Director, Regenerative Medicine, Pfizer, Inc
- Dr Ann Tsukamoto, Executive Vice President, Research & Development, StemCells, Inc
- Dr Doug Jolly, Executive Vice President of Research & Product Development, Tocagen, Inc
- Dr Akihiro Shimosaka, Director, Research & Development Division, Research Foundation for Community Medicine
- Dr Lincoln Tsang, Partner, Arnold & Porter LLP London
- Jeffrey M. Ostrove, PhD, President & CEO, Ceregene, Inc
- Dr Scott R. Burger, Principal, Advanced Cell & Gene Therapy
- Professor Ryuichi Morishita, Professor, Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine & Board Member AnGes MG

©Copyright Phacilitate Limited 2010
|

»Click here to download the 2010 Main Announcement
» Click here to download the previous three Cell & Gene Therapy Forum Main Announcements

Over 50 sponsors and exhibitors participated in 2010.
Click here to find out how your company can participate.
|